“…Dysbiosis is disturbances in the function and composition of the microbiota driven by environmental and host-related factors ( Leshem et al., 2019 ). This process may be involved in the pathogenesis of many diseases, such as IBD, IBS ( Cui et al., 2021 ), multiple sclerosis ( Engen et al., 2020 ; Li et al., 2020 ), hepatic encephalopathy ( Kao et al., 2016 ; Madsen et al., 2021 ), cancer ( Chen et al., 2019 ; Kaźmierczak-Siedlecka et al., 2020 ; Zhu H. et al, 2020 ) and metabolic syndrome ( Yu et al., 2020 ). Targeting the disturbed microbiota, which may be achieved by dietary interventions, probiotics, prebiotics, antibiotics, and FMT, might affect the progress of these conditions.…”